Clinical Trials Browser

Phase 2/3 × OTHER × Head & Neck × Clear all

NCT02135042 2026-03-18

Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

Phase 2/3 Active not recruiting

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT06030440 2026-03-13

DIREKHT2

Phase 2/3 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT05050162 2026-03-03

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

Phase 2/3 Suspended

Carcinoma, Oropharyngeal Neoplasms

NCT07440290 2026-02-27

DETERMINE

Phase 2/3 Not yet recruiting

CNSEndocrineGastrointestinalGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Glioma, Histiocytosis, Langerhans-Cell, Laryngeal Neoplasms, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

NCT07434206 2026-02-25

Safety and Efficacy of Dexmedetomidine in Controlling Hemodynamics During Resection of Active Thyroid Secreting Tumors

Phase 2/3 Active not recruiting

Thyroid Neoplasms

NCT04333537 2026-01-14

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Phase 2/3 Recruiting

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms

NCT07310758 2025-12-30

Contrast-enhanced Ultrasound for Sentinel Node Detection

Phase 2/3 Recruiting

BreastDermatologicHead & Neck

Breast Neoplasms, Head and Neck Neoplasms, Melanoma

NCT05768178 2025-11-24

DETERMINE

Phase 2/3 Recruiting

CNSDermatologicEndocrineGastrointestinalGynecologicHead & NeckMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Glioma, Laryngeal Neoplasms, Melanoma, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

NCT05891769 2025-09-10

18FCH

Phase 2/3 Recruiting

Parathyroid Neoplasms

NCT05429099 2025-07-24

ViPMR

Phase 2/3 Recruiting

Mouth Neoplasms

NCT03498183 2025-06-06

MIBI-THYR

Phase 2/3 Completed

Malignancy of Thyroid Nodules

NCT00248235 2024-11-05

Resistance Exercise Training for the Shoulder and Neck Following Surgery for Head and Neck Cancer

Phase 2/3 Completed

Head and Neck Neoplasms, Motor Activity

NCT05865548 2024-08-13

Addition of Aspirin to Standard of Care in Oral Cancer

Phase 2/3 Completed

Mouth Neoplasms

NCT03952065 2024-06-26

IT or IA Infusion of PD1/PDL1/CTLA4 Inhibitors Versus IV for Immunotherapy of Head/Neck Cancers (HNC)

Phase 2/3 Recruiting

Head and Neck Neoplasms

NCT02923258 2024-06-20

Postoperative CCRT With Docetaxel vs Cisplatin in High Risk Oral Cavity Cancer

Phase 2/3 Completed

Squamous Cell Carcinoma of Head and Neck

NCT01398085 2024-05-08

IoN

Phase 2/3 Active not recruiting

EndocrineHead & Neck

Thyroid cancer, Hurthle cell, Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

NCT06241599 2024-02-05

A Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

Phase 2/3 Recruiting

Nasopharyngeal Carcinoma, Recurrence

NCT05125055 2023-11-22

Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC

Phase 2/3 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT06016400 2023-08-29

Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell Carcinoma

Phase 2/3 Unknown

Squamous Cell Carcinoma of Head and Neck, Stomatitis

NCT00997906 2022-09-29

Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC

Phase 2/3 Unknown

Head and Neck Neoplasms

NCT02548715 2022-07-13

LSHT

Phase 2/3 Withdrawn

Hypothyroidism, Neoplasms, Postoperative Complications

NCT05433597 2022-06-27

A Two-blinded, Multicentre, Phase II/III RCT of Concurrent Chemo-radiotherapy Combined or Not Combined With TNF as the Therapy for LA-NPC

Phase 2/3 Not yet recruiting

Nasopharyngeal Carcinoma

NCT05023863 2021-08-27

The Effect of Alpha Lipoic Acid on the Incidence and Severity of Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients

Phase 2/3 Unknown

Head & NeckOther

Head and Neck Neoplasms, Mucositis

NCT04933357 2021-06-21

MART

Phase 2/3 Unknown

Head and Neck Neoplasms

NCT04890522 2021-05-18

An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC

Phase 2/3 Not yet recruiting

Nasopharyngeal Carcinoma, Neoplasm Metastasis

NCT00894101 2018-07-20

Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation

Phase 2/3 Withdrawn

Head and Neck Neoplasms

NCT03344068 2017-12-22

Early and Whole Course Nutritional Support by Nutren® Optimum During IMRT for Nasopharyngeal Carcinoma

Phase 2/3 Unknown

Nasopharyngeal Carcinoma

NCT01434394 2017-08-21

EAGLE

Phase 2/3 Completed

Mouth Neoplasms, Oropharyngeal Neoplasms

NCT01542931 2017-08-21

TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma

Phase 2/3 Completed

Squamous Cell Carcinoma of Head and Neck

NCT00002533 2016-12-15

Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer

Phase 2/3 Completed

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Infections, Esthesioneuroblastoma, Olfactory

NCT01083550 2016-11-29

Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer

Phase 2/3 Completed

Thyroid Neoplasms

NCT01137097 2016-04-21

LSLNB

Phase 2/3 Completed

Thyroid Neoplasms

NCT01149161 2016-04-21

Extent of Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma

Phase 2/3 Unknown

Carcinoma, Thyroid Diseases

NCT00123760 2016-02-25

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer

Phase 2/3 Completed

10,838 enrolled

CNSGastrointestinalHead & NeckLymphoidThoracic

Brain Neoplasms, Lung Neoplasms, Lymphoma, Thyroid Neoplasms, Colorectal Neoplasms

NCT01596933 2015-03-10

NUTRIOM

Phase 2/3 Completed

Head and Neck Neoplasms, Weight Loss

NCT00934739 2015-02-25

A Study of High-Risk Oral Cavity Cancer

Phase 2/3 Terminated

Mouth Neoplasms

NCT01761747 2014-12-23

Ponatinib for Squamous Cell Lung and Head and Neck Cancers

Phase 2/3 Terminated

3 enrolled 9 charts

Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT01854203 2013-07-30

NPC

Phase 2/3 Unknown

Nasopharyngeal Carcinoma

NCT01598402 2013-07-15

PANTAP

Phase 2/3 Unknown

Head and Neck Neoplasms

NCT01689558 2013-03-12

Recombine Endostatin With Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation in Advanced Nasopharynx Cancer

Phase 2/3 Unknown

Nasopharyngeal Neoplasms

NCT01335828 2013-01-25

SWETHY

Phase 2/3 Completed

Thyroid Nodule

NCT00778908 2012-08-21

Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 2/3 Completed

Nasopharyngeal Carcinoma

NCT01616316 2012-06-11

Efficacy of Subfascial Approach in Thyroidectomy to Quality of Life in Thyroid Disease Patients

Phase 2/3 Completed

Thyroid Neoplasms

NCT00363441 2012-01-19

A Study of Conventional 3D Radiation vs. Intensity-Modulated Radiation in Squamous Cell Cancer of the Head and Neck

Phase 2/3 Withdrawn

Head and Neck Neoplasms, Neoplasms, Squamous Cell